Beavis&butthead

Beavis&butthead

TBA
599 Views
Beavis is Back, a mischievous meme coin inspired by the famous character. It offers scalability and security, processing up to 10,000 transactions per second without the front running problem. Beavis has its own wallet for payments, swaps, staking, liquidity provision, tokenization, and lending. It aims to obtain its own EMI banking license for independent payment processing. Compared to Visa and MasterCard, Beavis is cost-effective and 5 times cheaper. It provides innovative and secure features, serving as an alternative to popular cryptocurrencies and traditional payment methods. Join the Beavis community today to learn more.
3.9
TOTAL SCORE
2.7
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Dates: TBA
Whitelist/KYC: Whitelist
Token info
Ticker: Beavis
Platform: Binance Chain
Financial
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Sponsy
Sponsy is disrupting the sponsorship industry. It is a one-stop online solution for sponsors and sponsees to conduct sponsorship deals. By tokenizing sponsorship assets and decentralizing decision-making, we do not only reduce costs, but also provide sponsees with a wider choice of sponsorship opportunities and make sponsorships available to every business.
Upcoming
ECTA
ECTA (Efficient Collaboration Team Autonomous) is the first blockchain-based trust protocol for global employability of developers. The concept, empowered by the proven AI tools, aims to solve the inefficiencies related to the time loss, verification of online profiles, talents discovery (especially in the low-middle income countries) and safe way to conduct business (payment solution with the power of smart contracts). While working on ECTA platform, besides collecting their earnings in ECTA tokens (ERC20) developers are having a unique possibility to earn (mine) ECTA non-fungible tokens (ERC721) as a reward for every task completed - which serve as proof of their skills and increase their reputation. AI component of the platform helps companies worldwide discover and employ these developers in a safe and productive way for both sides.
Upcoming
AGATE
Agate is the world's most comprehensive decentralized blockchain platform for instant payment without volatility risk to mainstream crypto adoption.
Upcoming
CoinMarketFeed
CoinMarketFeed is world’s crypto social network. Connect with thousands of crypto traders and blockchain enthusiasts, Access real time cryptocurrency data, news and alerts. Buy price predictions directly from the best crypto traders globally or invest directly into their smart portfolio.
Upcoming
Quantler
Quantler is a blockchain for creating, analysing, sharing and running of decentralized structured investment products. Create structured products (such as an ETF) in equities or cryptocurrencies using themes. As there are a lot of the tokenized products being launched (currently over 1 900 available) the structured products for these assets are lacking behind (such as sector-based ETFs). Using Quantler’s blockchain anyone can create structured products (for regular assets such as Equities and cryptocurrencies) and run them on a decentralized network (much like smart contracts). Quantler also allows for regular assets, for this market Quantler’s solution is more flexible and has a lower costs base (targeted for exchanges, family offices and investment managers). The QUANT token’s intrinsic value is dependent on the AUM (asset under management) by the entire network. Quantler is like a Vanguard or BlackRock, but then in the form of a network.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.